- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech High Growth Potential Companies
U.S. Pharmaceuticals & Biotech High Growth Potential Companies
Results
168
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
168 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
AXSM | US$85.23 | 1.8% | 11.9% | US$4.1b | US$124.06 | PS16.1x | E65.0% | n/a | ||
ZVRA | US$6.23 | -2.2% | 34.3% | US$261.2m | US$19.00 | PS9.4x | E65.8% | n/a | ||
TGTX | US$19.98 | -5.9% | 0.8% | US$2.8b | US$31.63 | PE69.4x | E48.0% | n/a | ||
SRPT | US$147.56 | 2.6% | 39.8% | US$13.8b | US$198.28 | PE825.5x | E39.9% | n/a | ||
IMGN | US$31.23 | 6.6% | 617.9% | US$8.4b | US$28.95 | PS29.1x | E45.8% | n/a | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | ||
IVVD | US$1.34 | 6.3% | -6.9% | US$149.1m | US$9.23 | PB0.9x | E69.7% | n/a | ||
ARDX | US$5.62 | -2.3% | 61.0% | US$1.3b | US$10.94 | PS8.3x | E64.0% | n/a | ||
ITCI | US$80.84 | 7.9% | 30.5% | US$8.2b | US$93.87 | PS16.6x | E60.2% | n/a | ||
FOLD | US$10.35 | -2.4% | -22.5% | US$3.1b | US$17.36 | PS7.2x | E60.8% | n/a | ||
EOLS | US$12.30 | 2.9% | 57.3% | US$788.3m | US$22.29 | PS3.5x | E66.4% | n/a | ||
AVDL | US$16.30 | 0.2% | n/a | US$1.6b | US$23.65 | PS28.4x | E61.3% | n/a | ||
LEGN | US$59.14 | 1.5% | -21.9% | US$10.9b | US$82.63 | PS31.4x | E63.6% | n/a | ||
APLS | US$38.88 | 2.5% | 21.1% | US$4.5b | US$74.76 | PS9x | E63.3% | n/a | ||
ISEE | US$39.95 | 0.9% | 236.3% | US$5.5b | US$40.00 | PB11.6x | E59.0% | n/a | ||
SPRY | US$10.40 | -8.2% | 48.6% | US$1.0b | US$19.00 | PS100771.1x | E57.7% | n/a | ||
URGN | US$16.37 | -3.1% | 81.7% | US$697.4m | US$43.88 | PS8x | E58.1% | n/a | ||
VNDA | US$6.17 | -0.8% | -5.2% | US$366.6m | US$8.11 | PS2x | E83.5% | n/a | ||
TVTX | US$9.66 | -6.1% | -40.9% | US$744.5m | US$14.86 | PS4.7x | E67.6% | n/a | ||
ENSC | US$0.41 | -10.6% | -80.4% | US$3.0m | US$13.38 | PS1.8x | E84.6% | n/a | ||
CLRB | US$2.37 | -10.1% | 25.0% | US$83.7m | US$15.50 | PB9.3x | E65.7% | n/a | ||
EVOK | US$0.48 | -11.6% | -70.6% | US$4.3m | US$7.00 | PB1.2x | E110.6% | n/a | ||
OPTN | US$1.08 | 0% | -1.8% | US$147.7m | US$3.75 | PS2.1x | E61.6% | n/a | ||
ASND | US$134.38 | -1.6% | 53.5% | US$7.7b | US$181.92 | PS21.6x | E66.9% | n/a |